These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 9084963)
1. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. De Vos P; De Haan BJ; Wolters GH; Strubbe JH; Van Schilfgaarde R Diabetologia; 1997 Mar; 40(3):262-70. PubMed ID: 9084963 [TBL] [Abstract][Full Text] [Related]
2. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Fritschy WM; de Vos P; Groen H; Klatter FA; Pasma A; Wolters GH; van Schilfgaarde R Transpl Int; 1994 Jul; 7(4):264-71. PubMed ID: 7916926 [TBL] [Abstract][Full Text] [Related]
3. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. van Schilfgaarde R; de Vos P J Mol Med (Berl); 1999 Jan; 77(1):199-205. PubMed ID: 9930963 [TBL] [Abstract][Full Text] [Related]
4. Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Cole DR; Waterfall M; McIntyre M; Baird JD Diabetologia; 1992 Mar; 35(3):231-7. PubMed ID: 1563581 [TBL] [Abstract][Full Text] [Related]
5. Alginate modification improves long-term survival and function of transplanted encapsulated islets. Mallett AG; Korbutt GS Tissue Eng Part A; 2009 Jun; 15(6):1301-9. PubMed ID: 18950258 [TBL] [Abstract][Full Text] [Related]
6. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027 [TBL] [Abstract][Full Text] [Related]
7. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. De Vos P; De Haan B; Van Schilfgaarde R Biomaterials; 1997 Feb; 18(3):273-8. PubMed ID: 9031730 [TBL] [Abstract][Full Text] [Related]
8. Long-term Efficacy and Biocompatibility of Encapsulated Islet Transplantation With Chitosan-Coated Alginate Capsules in Mice and Canine Models of Diabetes. Yang HK; Ham DS; Park HS; Rhee M; You YH; Kim MJ; Shin J; Kim OY; Khang G; Hong TH; Kim JW; Lee SH; Cho JH; Yoon KH Transplantation; 2016 Feb; 100(2):334-43. PubMed ID: 26479281 [TBL] [Abstract][Full Text] [Related]
9. The fate of transplanted encapsulated islets in spontaneously diabetic BB/Wor rats. Gotfredsen CF; Stewart MG; O'Shea GM; Vose JR; Horn T; Moody AJ Diabetes Res; 1990 Dec; 15(4):157-63. PubMed ID: 2132404 [TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and function of microencapsulated pancreatic islets. Figliuzzi M; Plati T; Cornolti R; Adobati F; Fagiani A; Rossi L; Remuzzi G; Remuzzi A Acta Biomater; 2006 Mar; 2(2):221-7. PubMed ID: 16701881 [TBL] [Abstract][Full Text] [Related]
12. Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Langlois G; Dusseault J; Bilodeau S; Tam SK; Magassouba D; Hallé JP Acta Biomater; 2009 Nov; 5(9):3433-40. PubMed ID: 19520193 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. De Vos P; Hillebrands JL; De Haan BJ; Strubbe JH; Van Schilfgaarde R Transplantation; 1997 Mar; 63(6):824-30. PubMed ID: 9089221 [TBL] [Abstract][Full Text] [Related]
14. The effect of capsule composition on the viability and biocompatibility of sodium alginate/poly-L-lysine encapsulated islets. Clayton HA; London NJ; Colloby PS; James RF; Bell PR Transplant Proc; 1992 Jun; 24(3):956. PubMed ID: 1604683 [No Abstract] [Full Text] [Related]
15. Synergistic effect of microencapsulation and immunoalteration on islet allograft survival in bioartificial pancreas. Zekorn TD; Horcher A; Siebers U; Federlin K; Bretzel RG J Mol Med (Berl); 1999 Jan; 77(1):193-8. PubMed ID: 9930962 [TBL] [Abstract][Full Text] [Related]
16. Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts. Fritschy WM; Strubbe JH; Wolters GH; van Schilfgaarde R Diabetologia; 1991 Aug; 34(8):542-7. PubMed ID: 1936656 [TBL] [Abstract][Full Text] [Related]
17. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Kulseng B; Skjåk-Braek G; Ryan L; Andersson A; King A; Faxvaag A; Espevik T Transplantation; 1999 Apr; 67(7):978-84. PubMed ID: 10221481 [TBL] [Abstract][Full Text] [Related]
18. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets. King A; Lau J; Nordin A; Sandler S; Andersson A Diabetes Technol Ther; 2003; 5(4):653-63. PubMed ID: 14511420 [TBL] [Abstract][Full Text] [Related]
19. Biodritin microencapsulated human islets of Langerhans and their potential for type 1 diabetes mellitus therapy. Campos-Lisbôa AC; Mares-Guia TR; Grazioli G; Goldberg AC; Sogayar MC Transplant Proc; 2008 Mar; 40(2):433-5. PubMed ID: 18374092 [TBL] [Abstract][Full Text] [Related]
20. Factors influencing functional survival of microencapsulated islet grafts. de Vos P; de Haan BJ; de Haan A; van Zanten J; Faas MM Cell Transplant; 2004; 13(5):515-24. PubMed ID: 15565864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]